(Q51836423)

13 April 2018

title

Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model. (English)

1 reference

13 April 2018

0 references

Gil R Faria

1

1 reference

13 April 2018

John R Preto

series ordinal

2

1 reference

13 April 2018

José Costa-Maia

series ordinal

3

1 reference

13 April 2018

publication date

1 April 2013

1 reference

13 April 2018

published in

Obesity Surgery

1 reference

13 April 2018

volume

23

1 reference

13 April 2018

issue

4

1 reference

13 April 2018

page(s)

460-466

1 reference

13 April 2018

Are bariatric surgical outcomes worth their cost? A systematic review

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Development and validation of a bariatric surgery mortality risk calculator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Bariatric surgery: cost-effectiveness and budget impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-utility of bariatric surgery for morbid obesity in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness of bariatric surgery: should it be universally available?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

21 January 2018

Type 2 diabetes outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness of gastric bypass for severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

Bariatric surgery is a cost-saving for the healthcare system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0816-8

SAGES guideline for clinical application of laparoscopic bariatric surgery

21 January 2018

1 reference

12 December 2020

Risks and benefits of bariatric surgery: current evidence

1 reference

12 December 2020

Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity

1 reference

12 December 2020

Comparison of the costs associated with medical and surgical treatment of obesity

1 reference

12 December 2020

Direct medical costs unique to people with arthritis.

1 reference

12 December 2020

Impact of gastric bypass operation on survival: a population-based analysis

1 reference

12 December 2020

[Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB)]

1 reference

12 December 2020

Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events.

1 reference

12 December 2020

Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective

1 reference

12 December 2020

Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine

1 reference

12 December 2020

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

10.1007/S11695-012-0816-8

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018